Phase II study of adjuvant docetaxel and carboplatin with/without doxorubicin and cyclophosphamide in triple negative breast cancer: a randomised controlled clinical trial

AIM OF THE STUDY: The aim of this trial was to compare overall survival (OS), disease-free survival (DFS), and toxicity of two adjuvant regimens in triple negative patients with Iranian ethnicity. MATERIAL AND METHODS: In a phase II trial, patients with previously untreated triple negative breaststr...

Descripción completa

Detalles Bibliográficos
Autores principales: Najafi, Safa, Payandeh, Mehrdad, Sadeghi, Masoud, Shafaei, Vahideh, Shojaiyan, Fateme, Abbasvandi, Fereshte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385483/
https://www.ncbi.nlm.nih.gov/pubmed/28435404
http://dx.doi.org/10.5114/wo.2017.66661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385483/
https://www.ncbi.nlm.nih.gov/pubmed/28435404
http://dx.doi.org/10.5114/wo.2017.66661

Ejemplares similares